Vaccine development

We are proud to fast-track the development of a COVID-19 vaccine that could bring hope to millions of people around the world.

The COVID-19 vaccine being developed by the team at the University of Queensland (UQ) is the only one in Australia (and one of only nine, globally) being tasked by the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI).


On 17 March 2020, CEPI and the University of Queensland — one of our country’s leading research institutions— announced a partnering agreement to develop a “molecular clamp” vaccine platform, a transformative technology that enables targeted and rapid vaccine production against multiple viral pathogens.

Established in 2017, CEPI’s aim is to speed up the development of vaccines. The organisation was created following the Ebola outbreak in West Africa that killed more than 11,000 people.

The spread of COVID-19 has become a humanitarian and economic crisis. CEPI has moved quickly and urgently to coordinate with global health authorities and partners to rapidly develop vaccine candidates against the disease.

Bill and Melinda Gates Foundation

CEPI is backed by the Bill and Melinda Gates Foundation and the Norwegian Government. The Bill & Melinda Gates Foundation is guided by the belief that every life has equal value. They aspire to help all people lead healthy, productive lives. 

CEPI's role in accelerating development of vaccines

How vaccines work

Last updated 06 May, 2020
Creative Commons Attribution-NoDerivs 3.0 Australia (CC BY-ND 3.0) ( )

Is your feedback about

Feedback on government services, departments and staff

Please use our complaints and compliments form.